| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely permethrin stain 50 milligram/1 gram conventional release cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Boots covering cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Veil cover cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dermablend cover cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Covermark classic foundation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product manufactured as oropharyngeal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Minor skin infection preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical abrasive agents |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical antipruritic (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ethyl-2-cyanoacrylate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| 2-octyl cyanoacrylate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Local astringent and detergent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Emollients, demulcents and protectant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sclerosing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adapalene 0.1% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely adapalene 1 microgram/1 milligram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Teniposide 50mg injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Zinc sulfate 25mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tazarotene 0.1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Selenium sulfide 25 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tazarotene 0.05% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum chloride 250mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum sulfate 0.5mg/inch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Trichloroacetic acid 80% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum sulfate 0.48mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum sulfate 0.85mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum sulfate 1.45mg/in |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum sulfate 15% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum sulfate 25% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum sulfate 0.2mg/10mm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum sulfate 0.35mg/10mm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum sulfate 0.45mg/10mm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Benzyl penicilloyl-polylysin 0.06mmo/0.25mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Becaplermin 100 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Zinc sulfate 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Teniposide 10mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum potassium sulfate 0.138mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum potassium sulfate 0.244mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum potassium sulfate 0.68mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminum potassium sulfate 0.28mg/cm |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminium chloride 250 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tretinoin 0.05% liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Trichloroacetic acid 15% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely isotretinoin 10 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely isotretinoin 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Calcipotriene hydrate 0.005% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Calcipotriene 0.005% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cantharidin 0.7% liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Calcipotriene 0.005% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tretinoin 1 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Podofilox 0.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Podofilox 0.5% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Talc 5.00g aerosol (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Benzyl penicilloyl-polylysin 0.06mmo injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tretinoin 1 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alitretinoin 0.1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Monobenzone 20% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chloroxylenol + hydrocortisone + pramoxine hydrochloride 1mg/10mg/10mg drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mequinol 20 mg/mL and tretinoin 100 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing isotretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing pimecrolimus (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pimecrolimus 1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| onguent d'acides benzoïque et salicylique |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Azelaic acid (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chloroxylenol |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salicylic acid (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dithranol |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Benzoic acid |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Podophyllum resin (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydroquinone (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Crotamiton (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Proliferant agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tacrolimus monohydrate 0.03% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tacrolimus monohydrate 0.1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical tacrolimus |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allantoin (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Enbucrilate |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cell stimulant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Depigmenting agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical corticosteroid, group III |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Benzyl benzoate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tar-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tretinoin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium tetradecyl sulfate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| astringent drug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Coal tar-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Skin agent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminium chloride-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical corticosteroid, group VI |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Teniposide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium tetradecyl |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical corticosteroid, group I |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical corticosteroid, group IV |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Skin anti-inflammatory agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| goudron ou baume |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bufexamac |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Selenium (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bromine (substance) |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| anti-infectieux cutané |
Is a |
False |
agent cutané |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]